However, comprehensive and in-depth research is still lacking on the expression characteristics of GPAA1 in pan-cancers, its association with CRC immune subtypes and genomic instability, as well as its regulatory mechanisms on the malignant phenotype of CRC cells and anti-tumor immune responses. The gene discussed is GPAA1; the disease is cancer.